Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5, indicating a new revision release of the study record.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a new revision label v3.6.4, replacing the previous v3.6.3, indicating a small update to the page metadata.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.6.3 has been added and the previous revision v3.6.2 removed, updating the page's version identifier. This is an internal software version update and does not alter the displayed study information or user-facing content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page shows an updated Revision tag from v3.6.0 to v3.6.2. This indicates a minor internal update to the page's software/versioning and does not change the study information presented.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now states that recruitment has ended, and there are several minor UI edits including new navigation/help items and a wording change for the Intervention/Treatment label, plus an updated revision footer.SummaryDifference0.4%

- Check79 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new build of the page was deployed. This reflects a metadata-level update rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.